On behalf of the of The Pennsylvania Veterinary Medical Association, we want to thank Governor Shapiro’s Office for their quick action to hear our concerns and their willingness to work with us regarding the scheduling of xylazine as a Schedule III controlled substance.

Xylazine is an FDA-approved prescription sedative with pain-relieving and muscle relaxing properties for use in animals. It is one of the most widely used veterinary drugs across many species, including cats, dogs, horses, cattle, deer, elk, rats, mice, wildlife, and zoo animals.